|
Huss, Wendy J; Gray, Danny R; Tavakoli, Keyvan et al. (2007) Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model. Neoplasia 9:938-50
|
|
Winter, S F; Acevedo, V D; Gangula, R D et al. (2007) Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2. Oncogene 26:4897-907
|
|
Huss, Wendy J; Gray, Danny R; Greenberg, Norman M et al. (2005) Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res 65:6640-50
|
|
Huss, Wendy J; Lai, Lihua; Barrios, Roberto J et al. (2004) Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer. Prostate 61:142-52
|
|
Jin, Chengliu; McKeehan, Kerstin; Guo, Wei et al. (2003) Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate. Cancer Res 63:8784-90
|
|
Hernandez, Inmaculada; Maddison, Lisette A; Wei, Yongli et al. (2003) Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol Cancer Res 1:1036-47
|
|
Huss, Wendy J; Barrios, Roberto J; Greenberg, Norman M (2003) SU5416 selectively impairs angiogenesis to induce prostate cancer-specific apoptosis. Mol Cancer Ther 2:611-6
|
|
Huss, Wendy J; Barrios, Roberto J; Foster, Barbara A et al. (2003) Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression. Prostate 54:8-16
|
|
Kazansky, Alexander V; Spencer, David M; Greenberg, Norman M (2003) Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system. Cancer Res 63:8757-62
|
|
Uzgare, Aarti R; Kaplan, Paula J; Greenberg, Norman M (2003) Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Prostate 55:128-39
|
Showing the most recent 10 out of 21 publications
